These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 2043927

  • 1. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
    Merritt JE, Brown AM, Bund S, Cooper DG, Egan JW, Hallam TJ, Heagerty AM, Hickey DM, Kaumann AJ, Keen M.
    Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927
    [Abstract] [Full Text] [Related]

  • 2. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 3. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [Abstract] [Full Text] [Related]

  • 4. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
    Jones RL, Qian YM, Wise H, Wong HN, Lam WL, Chan HW, Yim AP, Ho JK.
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
    [Abstract] [Full Text] [Related]

  • 5. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S, Brassard CL, Arnold AJ, Meanwell NA, Fleming JS, Keely SL.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA, Jones RL, MacDermot J, Wilson NH.
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.
    Baxter GS, Clayton JK, Coleman RA, Marshall K, Sangha R, Senior J.
    Br J Pharmacol; 1995 Sep; 116(1):1692-6. PubMed ID: 8564239
    [Abstract] [Full Text] [Related]

  • 8. Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.
    Chow KB, Wong YH, Wise H.
    Br J Pharmacol; 2001 Dec; 134(7):1375-84. PubMed ID: 11724742
    [Abstract] [Full Text] [Related]

  • 9. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P, White BP, Humphrey PP.
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [Abstract] [Full Text] [Related]

  • 10. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
    Seiler SM, Brassard CL, Federici ME, Romine J, Meanwell NA.
    Prostaglandins; 1997 Jan; 53(1):21-35. PubMed ID: 9068064
    [Abstract] [Full Text] [Related]

  • 11. The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
    Stürzebecher S, Witt W.
    Prostaglandins; 1988 Dec; 36(6):751-60. PubMed ID: 2469101
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ring.
    Meanwell NA, Rosenfeld MJ, Wright JJ, Brassard CL, Buchanan JO, Federici ME, Fleming JS, Gamberdella M, Hartl KS, Zavoico GB.
    J Med Chem; 1993 Nov 26; 36(24):3871-83. PubMed ID: 8254619
    [Abstract] [Full Text] [Related]

  • 14. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA, Jones RL, Peesapati V, Will SG, Wilson NH.
    Br J Pharmacol; 1985 Mar 26; 84(3):595-607. PubMed ID: 2580580
    [Abstract] [Full Text] [Related]

  • 15. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR, Belch JJ, Lowe GD, Barbenel JC, Forbes CD.
    Haemostasis; 1987 Mar 26; 17(3):147-53. PubMed ID: 2440771
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ, Jones RL, Wilson NH.
    Br J Pharmacol; 1986 Jan 26; 87(1):97-107. PubMed ID: 2420404
    [Abstract] [Full Text] [Related]

  • 17. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
    Davis RJ, Murdoch CE, Ali M, Purbrick S, Ravid R, Baxter GS, Tilford N, Sheldrick RL, Clark KL, Coleman RA.
    Br J Pharmacol; 2004 Feb 26; 141(4):580-5. PubMed ID: 14744815
    [Abstract] [Full Text] [Related]

  • 18. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 2000 Jan 26; 292(1):238-46. PubMed ID: 10604953
    [Abstract] [Full Text] [Related]

  • 19. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A, Folco GC, Fumagalli R, Nicosia S, Noe MA, Oliva D.
    Br J Pharmacol; 1987 Jan 26; 90(1):255-61. PubMed ID: 3545351
    [Abstract] [Full Text] [Related]

  • 20. The relaxing activity of iloprost and prostaglandin E2 in the isolated various smooth muscle strips of the rabbit.
    Ercan ZS, Türker RK.
    Pharmacology; 1985 Jan 26; 31(2):61-6. PubMed ID: 2410937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.